16:11:30 EDT Sat 20 Apr 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Nugen Medical Devices Inc
Symbol NGMD
Shares Issued 200,125,682
Close 2024-01-30 C$ 0.09
Market Cap C$ 18,011,311
Recent Sedar Documents

Nugen distributor Sol-M completes InsuJet training

2024-01-30 17:21 ET - News Release

Mr. Ian Heynen reports

NUGEN ANNOUNCES COMPLETION OF PRODUCT TRAINING WITH SOL MILLENNIUM AS EUROPEAN MARKETS EXPAND

As of Jan. 30, 2024, Sol-Millennium Medical Inc.'s (Sol-M) global sales and marketing team has now completed its in-depth clinical training of Nugen Medical Devices Inc.'s needle-free InsuJet medical device for sales and marketing throughout Europe.

Louise Cresswell, Nugen's vice-president of sales and marketing for the United Kingdom and clinical expert, provided specialized training to a group of seven Sol-M sales representatives and equipped them with the necessary tools to employ a detail-oriented and proficient sales strategy for the European markets.

Training specifically included detailed instructions and hands-on training of Nugen's InsuJet needle-free device to facilitate sales as it pertains to the diabetic markets in France and Spain.

"Well-attended sessions with very good interactions from Sol-M sales representatives enabled me to share our experiences, and clinician and patient feedback of the InsuJet system to help the Sol-M team to drive sales and product adoption in their target markets throughout Europe," commented Louise Cresswell, Nugen's VP of sales and marketing. "The engagement and outcome with Sol-M were overwhelmingly positive with fulfilment set to achieve and perhaps even exceed expectations. I am very, very pleased," said Ms. Creswell.

As planned, European order forecasts are to be received by Nugen from Sol-M in the coming weeks which is in keeping with expectations with first orders arriving before the end of Q1 2024.

"In January this year, I personally met overseas with Liang Lin, CEO of Sol-M, and am pleased to report a very positive relationship that will continue to grow further. After in-depth sales, marketing and promotion training with Sol-M, which took months to complete, we are delighted to now go to market with our co-branded InsuJet needle-free medical device and consumables," commented Ian Heynen, chief executive officer. "As I stated earlier, 2024 will be a very busy year reporting commercial progress and wins in all three of our business verticals."

About Sol-Millennium Medical Inc.

Sol-M, Nugen's distributor since July, 2023, for InsuJet in Canada, Brazil, France and Spain (see Nugen signs $204-million distribution agreement with global leader in the diabetic industry) are global leaders in the health care industry with five offices around the world. Sol-M is a high-growth global medical device company committed to improving the safety and well-being of health care workers and their patients with the design and development of innovative safety-engineered medical devices. Sol-M is one of the world's largest designers and distributors of needles, syringes and diabetic supplies, offering a broad portfolio of patented products with global brand recognition such as Sol-Care for safety sharps, Sol-M for conventional medical devices and Sol-Guard for immunization products.

About Nugen Medical Devices Inc.

Nugen is a leading developer of needle-free devices to administer therapeutics subcutaneously.

The company is marketing and selling its next-generation InsuJet needle-free injection system designed to improve the lives of millions of diabetics.

InsuJet is approved for sale in 42 countries around the world.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.